483 filings
Page 6 of 25
6-K
fkd2a4283rz
21 Nov 23
Topline Results Phase 3 MANIFEST-2 Study Pelabresib in First-Line Myelofibrosis November 2023 Gail, Living with Myelofibrosis since 2018
10:08am
6-K
eggpg
20 Nov 23
Current report (foreign)
4:55pm
6-K
ws9lb94qpkqcd3boax1v
20 Nov 23
Current report (foreign)
10:06am
6-K
i49cpd789xt
16 Nov 23
Current report (foreign)
10:22am
6-K
8gy5r7y sw0k19
16 Nov 23
Half-Year Report JANUARY – JUNE
9:25am
6-K
nwo6l
16 Nov 23
MorphoSys AG Reports First Nine Months and Third Quarter 2023 Financial Results
9:03am
6-K
hsg13s8ub5ysl
16 Nov 23
Third Quarter Interim Statement JANUARY – SEPTEMBER 2023
6:00am
6-K
sidjkohd52vv3js
14 Nov 23
Current report (foreign)
10:28am
6-K
viqfxh y23fqf10y7u8q
13 Nov 23
Current report (foreign)
10:07am
6-K
ttdexoa75w hrv4gz
13 Nov 23
Current report (foreign)
6:25am
6-K
z2tura
9 Nov 23
Current report (foreign)
10:32am
6-K
ywnuh4jve f1padvuivj
7 Nov 23
Current report (foreign)
10:05am
6-K
5904fi40 o9qa1xrv
2 Nov 23
MorphoSys To Showcase Phase 3 MANIFEST-2 Data on Pelabresib in Myelofibrosis in Oral Presentation at 2023 ASH Annual Meeting
9:20am
6-K
ugre9x
27 Oct 23
Current report (foreign)
10:26am
6-K
ps9641h 10n
26 Oct 23
Current report (foreign)
10:06am
6-K
utm3hwm19jnpl1
25 Oct 23
Current report (foreign)
11:28am
6-K
5u04gp0j
25 Oct 23
Current report (foreign)
10:30am
6-K
u4f0 7nu31q
24 Oct 23
Current report (foreign)
10:08am
6-K
b11 9rc5unr
23 Oct 23
Current report (foreign)
10:48am
6-K
12qv43np npqcc
19 Oct 23
Current report (foreign)
10:19am